About Emergent Biosolutions, Inc.
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company operates across three different segments, namely Commercial, Products, and Services. The key revenue is generated through the commercial segment which consists of NARCAN and other commercial products.
Market Cap
$0.28B
Employees
1,600
Listed Since
November 15, 2006
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.emergentbiosolutions.comPhone
240-631-3200
Headquarters
300 PROFESSIONAL DR
GAITHERSBURG, MD 20879
CIK
0001367644